MetLife, Inc. (NYSE:MET) Receives Average Rating of “Buy” from Brokerages

MetLife, Inc. (NYSE:MET) has been given an average rating of “Buy” by the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $94.1818.

MET has been the subject of a number of research analyst reports. Keefe, Bruyette & Woods cut their target price on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Mizuho set a $100.00 price objective on MetLife in a research note on Thursday, February 12th. Evercore set a $95.00 price objective on MetLife in a research report on Tuesday, February 10th. UBS Group increased their target price on MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Finally, Wells Fargo & Company lowered their target price on MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

MetLife Trading Down 1.5%

Shares of MET stock opened at $71.83 on Wednesday. MetLife has a 12 month low of $65.21 and a 12 month high of $85.00. The company has a market cap of $46.84 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 0.66 and a beta of 0.76. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The business’s 50 day moving average is $77.20 and its two-hundred day moving average is $78.72.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, topping analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion during the quarter, compared to analysts’ expectations of $31.43 billion. During the same period in the previous year, the company earned $2.08 earnings per share. MetLife’s revenue for the quarter was up 27.6% on a year-over-year basis. Equities analysts predict that MetLife will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be paid a $0.5675 dividend. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 3.2%. MetLife’s dividend payout ratio (DPR) is presently 48.30%.

Hedge Funds Weigh In On MetLife

Several large investors have recently bought and sold shares of MET. Union Savings Bank acquired a new stake in MetLife in the 4th quarter worth $181,000. Hsbc Holdings PLC raised its position in shares of MetLife by 29.1% during the fourth quarter. Hsbc Holdings PLC now owns 1,991,153 shares of the financial services provider’s stock valued at $157,440,000 after buying an additional 449,392 shares during the last quarter. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new stake in shares of MetLife in the fourth quarter valued at about $31,000. Bayban bought a new stake in shares of MetLife in the fourth quarter valued at about $64,000. Finally, SHP Wealth Management acquired a new stake in MetLife during the fourth quarter worth about $268,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.